Recent Updates
Recently added Catalysts
AKBA Positive Sentiment Score: 70/100

Akebia Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

Monday, November 24, 2025 1 min read
Key Takeaway: Akebia Therapeutics, a biopharmaceutical company dedicated to improving the lives of those affected by kidney disease, is set to participate in a Fireside Chat at the Piper Sandler 37th Annual Healthcare Conference. This event will occur on December 2, 2025, in New York City, where members of Akebia's executive team will speak. Interested parties can access a webcast of the presentation via the company's website following the conference.

Market Sentiment Analysis

POSITIVE FACTORS

  • Akebia Therapeutics is participating in a significant healthcare conference.
  • The event provides a platform for Akebia to engage with healthcare investors.
  • The company's focus on kidney disease aligns with an important health need.

Full Press Release Details

CAMBRIDGE, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that members of its executive team will participate in a Fireside Chat at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2 at 4:30 PM EST.
A webcast of the presentation can be accessed through the “Investors” section of Akebia’s website at https://ir.akebia.com following the conference.
The Piper Sandler Healthcare Conference will take place December 2-4, 2025, in New York City.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.
Akebia Therapeutics Contact
mcarrasco@akebia.com

Frequently Asked Questions

When will Akebia's Fireside Chat take place?

Akebia's Fireside Chat is scheduled for December 2, 2025, at 4:30 PM EST.

Where can I access the webcast of the presentation?

The webcast can be accessed in the 'Investors' section of Akebia's website.

What is the purpose of Akebia Therapeutics?

Akebia Therapeutics aims to improve the lives of individuals affected by kidney disease.

Where is Akebia Therapeutics located?

Akebia Therapeutics is headquartered in Cambridge, Massachusetts.

When was Akebia Therapeutics founded?

Akebia Therapeutics was founded in 2007.

Tags: AKBA Viatris Investor Conferences Healthcare Akebia Therapeutics kidney disease healthcare conference Piper Sandler biopharmaceutical
Last updated: Nov 24, 2025